MG1113

· GC Biopharma Corp

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MG1113, covering 2025-11-24 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b Study to Assess the Safety, Tolerability, PK and PD of MG1113 in Hemophilia Patient [Phase 1]